641 related articles for article (PubMed ID: 16934430)
21. Emergence of CTX-M-12 extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Bae IK; Lee YN; Hwang HY; Jeong SH; Lee SJ; Kwak HS; Song W; Kim HJ; Youn H
J Antimicrob Chemother; 2006 Dec; 58(6):1257-9. PubMed ID: 17003059
[TBL] [Abstract][Full Text] [Related]
22. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
Markovska R; Schneider I; Keuleyan E; Bauernfeind A
Clin Microbiol Infect; 2004 Aug; 10(8):752-5. PubMed ID: 15301679
[TBL] [Abstract][Full Text] [Related]
23. Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria.
Lavigne JP; Bonnet R; Michaux-Charachon S; Jourdan J; Caillon J; Sotto A
J Antimicrob Chemother; 2004 Apr; 53(4):616-9. PubMed ID: 14985275
[TBL] [Abstract][Full Text] [Related]
24. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
25. [Detection of CTX-M-15 type extended spectrum beta-lactamase in an Escherichia coli strain isolated from the urine sample of a hospitalized patient].
Aktaş Z; Gönüllü N; Schneider I; Bal C; Bauernfeind A
Mikrobiyol Bul; 2005 Oct; 39(4):421-9. PubMed ID: 16544543
[TBL] [Abstract][Full Text] [Related]
26. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.
Fernández A; Gil E; Cartelle M; Pérez A; Beceiro A; Mallo S; Tomás MM; Pérez-Llarena FJ; Villanueva R; Bou G
J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005
[TBL] [Abstract][Full Text] [Related]
27. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
Gudiol C; Calatayud L; Garcia-Vidal C; Lora-Tamayo J; Cisnal M; Duarte R; Arnan M; Marin M; Carratalà J; Gudiol F
J Antimicrob Chemother; 2010 Feb; 65(2):333-41. PubMed ID: 19959544
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness.
Kotapati S; Kuti JL; Nightingale CH; Nicolau DP
J Infect; 2005 Oct; 51(3):211-7. PubMed ID: 16230218
[TBL] [Abstract][Full Text] [Related]
29. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Rodríguez-Baño J; Alcalá J; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
J Antimicrob Chemother; 2009 Apr; 63(4):781-4. PubMed ID: 19223299
[TBL] [Abstract][Full Text] [Related]
30. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Perea EJ; Pérez-Cano R; Hernández JR; Pascual A
Clin Infect Dis; 2006 Jan; 42(1):37-45. PubMed ID: 16323089
[TBL] [Abstract][Full Text] [Related]
31. Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria.
Kang CI; Cha MK; Kim SH; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2014 May; 43(5):456-9. PubMed ID: 24690213
[TBL] [Abstract][Full Text] [Related]
32. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
[TBL] [Abstract][Full Text] [Related]
33. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Apisarnthanarak A; Kiratisin P; Saifon P; Kitphati R; Dejsirilert S; Mundy LM
Am J Infect Control; 2007 Nov; 35(9):606-12. PubMed ID: 17980240
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp.
Pitout JD; Hossain A; Hanson ND
J Clin Microbiol; 2004 Dec; 42(12):5715-21. PubMed ID: 15583304
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Azap OK; Arslan H; Serefhanoğlu K; Colakoğlu S; Erdoğan H; Timurkaynak F; Senger SS
Clin Microbiol Infect; 2010 Feb; 16(2):147-51. PubMed ID: 19689464
[TBL] [Abstract][Full Text] [Related]
36. [Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Chen YH; Yao WZ; Wu R; Zhou QT; Liu ZY; Zhang XW
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):815-9. PubMed ID: 19080534
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
Tian SF; Chen BY; Chu YZ; Wang S
Can J Microbiol; 2008 Sep; 54(9):781-5. PubMed ID: 18772941
[TBL] [Abstract][Full Text] [Related]
39. Extended-spectrum beta-lactamases and clinical outcomes: current data.
Ramphal R; Ambrose PG
Clin Infect Dis; 2006 Apr; 42 Suppl 4():S164-72. PubMed ID: 16544267
[TBL] [Abstract][Full Text] [Related]
40. CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: so far a sporadic event in Western Austria.
Prelog M; Fille M; Prodinger W; Grif K; Brunner A; Würzner R; Zimmerhackl LB
Infection; 2008 Aug; 36(4):362-7. PubMed ID: 18574554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
